| 28-Sep-2001 | S | Stock split of existing equity shares from every one existing equity share of Rs.10/- each into two equity shares of Rs.5/- each.
Reduced Paid-up Value - Rs.5/-
Reduced Paid-up Value w.e.f. - 10/10/2001
(For Demat Securities) | 25-Oct-2001 | |
| 07-May-2024 | D | Recommended a final dividend of Rs. 40/- (800%) per equity share of Rs. 5/- each for the financial year 2023-24. The dividend will be paid on or after five days from the date of declaration of the final dividend by the shareholders at the ensuing 40th Annual General Meeting (AGM) of the Company. | 16-Jul-2024 | |
| 10-May-2023 | D | Outcome of Board Meeting held on May 10, 2023 - Audited Financial Results and recommendation of Dividend for FY23
Recommended a final dividend of Rs. 40/- (800%) per equity share of Rs. 5/- each for the financial year 2022-23. The dividend will be paid on or after five days from the date of declaration of the final dividend by the shareholders at the 39th Annual General Meeting (AGM).
39th Annual General Meeting (AGM) of the members of the Company scheduled to be held on Thursday, July 27, 2023. The Register of Members and the Share Transfer Books of the Company shall remain closed from Wednesday, July 12, 2023, to Friday, July 14, 2023 (both days inclusive) for the purpose of the Dividend and Annual General Meeting of the Company. | 11-Jul-2023 | |
| 19-May-2022 | D | Dr Reddys Laboratories Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 19, 2022, inter alia, has recommended a final dividend of Rs. 30/- (600%) per equity share of Rs. 5/- each for the financial year 2021-22. The dividend will be paid on or after five days from the date of declaration of the final dividend by the shareholders at the 38th Annual General Meeting (AGM). | 11-Jul-2022 | |
| 14-May-2021 | D | Dr Reddys Laboratories Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 14, 2021, inter alia, have recommended a final dividend of Rs. 25/- (500%) per equity share of Rs. 5/- face value for the financial year 2020-21. The dividend will be paid on or after five days from the date of declaration of the final dividend by the shareholders at the 37th Annual General Meeting (AGM). The AGM date and book closure date for the purpose of the payment of final dividend will be announced in due course. | 09-Jul-2021 | |
| 20-May-2020 | D | Dr Reddys Laboratories Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 20, 2020, inter alia, have recommended a final dividend of Rs. 25/- (500%) per equity share of Rs. 5/- face value for the financial year 2019-20. The dividend will be paid on or after 5 days from the date of declaration of the final dividend by the shareholders at the 36th Annual General Meeting (AGM). | 13-Jul-2020 | |
| 17-May-2019 | D | Outcome of Board Meeting - Dividend | 15-Jul-2019 | |
| 22-May-2018 | D | Dr Reddys Laboratories Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 22, 2018, inter alia, have recommended a final dividend of Rs. 20/- (400%) per equity share of Rs. 5/- face value for the financial year 2017-18. The dividend on equity shares, if declared by the shareholders at the ensuing Annual General Meeting, will be credited / dispatched on or after August 01, 2018. | 16-Jul-2018 | |
| 10-May-2017 | D | Dr Reddys Laboratories Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 12, 2017, inter alia, have recommended a final dividend of Rs. 20/- (400%) per equity share of Rs. 5/- face value, for the financial year 2016-17. The dividend on equity shares, if declared by the shareholders at the ensuing Annual General Meeting, will be credited / dispatched on or after August 02, 2017. | 17-Jul-2017 | |
| 12-May-2016 | D | Dr Reddys Laboratories Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 12, 2016, inter alia, have recommended a final dividend of Rs.20/- (400%) per equity share of Rs.5/- face value, for the financial year 2015-16. The dividend on equity shares, if declared by the shareholders at the ensuing Annual General Meeting, will be credited / dispatched on or after August 1, 2016. | 18-Jul-2016 | |
| 12-May-2015 | D | Dr Reddys Laboratories Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 12, 2015, inter alia, have recommended a final dividend of Rs. 20/- (400%) per equity share of Rs.5/- face value, for the financial year 2014-15. The dividend on equity shares, if declared by the shareholder at the ensuing Annual General Meeting, will be credited / despatched on or after August 07, 2015. | 10-Jul-2015 | |
| 13-May-2014 | D | Dr Reddys Laboratories Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 13, 2014, inter alia, have recommended a final dividend of Rs. 18/- (360%) per equity share of Rs. 5/- face value, for the financial year 2013-14. The dividend on equity shares, If declared by the shareholders at the ensuing Annual General Meeting, will be credited / despatched on or after August 07, 2014. | 11-Jul-2014 | |
| 14-May-2013 | D | Dr Reddys Laboratories Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 14, 2013, inter alia, has recommended a final dividend of Rs. 15/- (300%) per equity share of Rs. 5/- face value, for the financial year 2012-13. The dividend on equity shares, if declared by the shareholders at the ensuing Annual Genera! Meeting, will be credited / despatched on or after August 07, 2013. | 12-Jul-2013 | |
| 11-May-2012 | D | Dr Reddys Laboratories Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 11, 2012, inter alia, have recommended a final dividend of Rs. 13.75 (275%) per equity share of Rs. 5/- face value, for the financial year 2011-12. The dividend on equity shares, if declared by the shareholders at the ensuing Annual General Meeting, will be credited / dispatched on or after July 27, 2012. | 28-Jun-2012 | |
| 13-May-2011 | D | Dr Reddys Laboratories Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 13, 2011, inter alia, have recommended a final dividend of Rs. 11.25 (225%) per equity share of Rs. 5/- face value, for the financial year 2010-11. The dividend on equity shares, if declared by the shareholders at the ensuing Annual General Meeting, will be credited / dispatched on or after July 28, 2011. | 30-Jun-2011 | |
| 06-May-2010 | D | Dr Reddys Laboratories Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 06, 2010, inter alia, have recommended a final dividend of Rs. 11.25 (225%) per equity share of Rs. 5/- face value, subject to the approval of shareholders at the ensuing Annual General Meeting. | 02-Jul-2010 | |
| 18-May-2009 | D | Dr Reddys Laboratories Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 18, 2009, inter alia, has recommended a final dividend of Rs 6.25 (125%) per equity share of Rs 5/- face value, subject to the approval of shareholders at the ensuing Annual General Meeting. | 03-Jul-2009 | |
| 20-May-2008 | D | Dr Reddys Laboratories Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 20, 2008, inter alia, has recommended a final dividend of 75% i.e. Rs 3.75 per share of the face value of Rs 5 subject to the shareholders approval. | 04-Jul-2008 | |
| 18-May-2007 | D | Dr Reddys Laboratories Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 18, 2007, inter alia, has transacted the following :
1. The Board of Directors has recommended a final dividend of 75% of face value of Rs 5 on the enhanced share capital due to bonus issue in August 2006. | 06-Jul-2007 | |
| 16-Jun-2006 | D | 100% Dividend | 07-Jul-2006 | |
| 07-May-2005 | D | Final | 07-Jul-2005 | |
| 09-Mar-2011 | B | SUB. :- Issue of Bonus Debentures of Dr. Reddy's Laboratories Ltd. (Scrip Code: 500124)
Trading Members of the Exchange are hereby informed that Dr. Reddy's Laboratories Ltd. has fixed the Record Date for the purpose of Issue of Bonus Debentures pursuant to the Scheme of Arrangement as sanctioned by Hon'ble High Court of Judicature, Andhra Pradesh at Hyderabad. The transactions in the equity shares of the Company should be on an ex-bonus basis with effect from the under mentioned date.
DEMATERIALISED SECURITIES - ROLLING SETTLEMENT SEGMENT
COMPANY NAME & CODE
Dr. Reddy's Laboratories Ltd.
(500124 & 600124)
RECORD DATE
18.03.2011
PURPOSE
6 (SIX) fully paid up unsecured redeemable non-convertible bonus debentures of Rs. 5/- each for every 1 (ONE) fully paid up equity share of Rs.5/- each held.
Ex-Bonus basis from Date & Sett. No.
17/03/2011 DR-246/2010-2011
Note:
The coupon rate on these debentures is 9.25% payable annually. These debentures would be redeemable, at par, at the end of 36 months from the date of allotment.
Trading Members of the Exchange are requested to take note of it. | 18-Mar-2011 | 6:1 |
| 04-Aug-2006 | B | Trading Members of the Exchange are hereby informed that, Dr. Reddy's Laboratories Ltd. has fixed the Record Date for the purpose of Bonus Issue. The transactions in the equity shares of the company should be on an ex-bonus basis with effect from the under mentioned date.
DEMATERIALISED SECURITIES - ROLLING SETTLEMENT SEGMENT
COMPANY NAME CODE
Dr. Reddy's Laboratories Ltd.
500124 & 600124
RECORD DATE
29/08/2006
PURPOSE
ONE fully paid-up Bonus equity share for every
ONE existing equity share held.
TRANSACTIONS IN EQUITY SHARES ON
Cum-Bonus basis up to Date &
Sett. No.
25/08/2006
DR-105/2006-2007
Ex-Bonus basis from Date & Sett. No.
28/08/2006
DR-106/2006-2007
Trading Members of the Exchange are requested to take note of it. | 29-Aug-2006 | 1:1 |
| 13-Aug-2024 | BC | Notice of Postal Ballot | 12-Sep-2024 | |
| 04-Sep-2024 | BC | Trading Members of the Exchange are hereby informed that the further new securities issued by the under mentioned companies are listed and admitted for trading on the Exchange with effect from Thursd | 05-Sep-2024 | |
| 09-Aug-2024 | BC | Trading Members of the Exchange are hereby informed that the further new securities issued by the under mentioned companies are listed and admitted for trading on the Exchange with effect from Monday | 12-Aug-2024 | |
| 07-May-2024 | BC | Audited Financial results for the quarter and year ended March 31, 2024
Change in Key Managerial Personnel | 01-Aug-2024 | |
| 07-May-2024 | BC | Audited Financial results for the quarter and year ended March 31, 2024
Change in Key Managerial Personnel
Outcome of Board Meeting
(As Per BSE Announcement dated on 27.07.2024) | 31-Jul-2024 | |